Results 131 to 140 of about 1,526 (167)
In Silico Design of Novel EpCAM-Binding Aptamers for Targeted Delivery of RNA Therapeutics. [PDF]
Driscoll J+5 more
europepmc +1 more source
ABSTRACT It is increasingly recognised by global research that extending out‐of‐home care (OOHC) until at least 21 years of age is the policy reform most likely to advance improved outcomes for care leavers. In recent years, all eight Australian jurisdictions (States and Territories) have introduced forms of extended care programs.
Philip Mendes+7 more
wiley +1 more source
This study presents novel macrocyclic peptides with low nanomolar affinity for CD59, an immunomodulatory cell surface receptor associated with human disease. Crystallographic and structure‐activity relationship (SAR) studies reveal peptide CP‐06 mimics the binding of biologically relevant CD59 interaction partners. Dimeric and lipidated CP‐06 analogues
Jasmine K. Bickel+12 more
wiley +2 more sources
Harnessing endogenous miRNA targeting ZIKV: A cutting-edge strategy to inhibit virus infection. [PDF]
Rosa RSM+5 more
europepmc +1 more source
Using a murine model of SAH, brain magnetic resonance imaging (MRI) was performed to confirm subarachnoid clot formation in the T2*‐weighted images sequence (left). Chest micro‐CT and DXA were performed to measure, respectively, the Hounsfield units (HU) and lean mass (LM) (middle) in order to test their relationship and ability to detect post‐SAH NPE (
Tatsushi Mutoh+3 more
wiley +1 more source
In vitro assessment of the effect of magnetic fields on efficacy of biosynthesized selenium nanoparticles by Alborzia kermanshahica. [PDF]
Eydelkhani M, Kiabi S, Nowruzi B.
europepmc +1 more source
Gene therapy for retinal diseases: From genetics to treatment. [PDF]
Khaparde A+5 more
europepmc +1 more source
uORF-targeting steric block antisense oligonucleotides do not reproducibly increase RNASEH1 expression. [PDF]
Ahlskog N+8 more
europepmc +1 more source
An Update: Enzymatic Synthesis for Industrial Applications
Biocatalysis has become a sustainable and cost‐competitive alternative to established chemical synthesis, enabling the enzyme‐based production of not only commodity chemicals but (non‐natural) amino acids, (rare) sugars, as well as synthetic nucleotides.
Thomas Bayer+4 more
wiley +1 more source